ABATE AS INDUSTRIES LIMITED
Latest filings
- ABATE AS signs franchise services deal for eye hospital expansion · Strategic Transactions
- Routine quarterly compliance filing under SEBI Regulation 74(5) · Compliance
- Trading window closed from Oct 1 ahead of Q2 results · Compliance
Snapshot
What the business is, and whether it's a good one at a fair price.
Operates an integrated platform spanning eye-care hospitals, retail, education, optical and talent services, with a Bahrain GCC presence through subsidiaries. The healthcare arm runs through Abate Eye Hospital and is the strategic growth focus — the hospital launched Kerala's first Alcon Vision Suite, a fully integrated digital ophthalmic ecosystem covering diagnosis, surgical planning, surgery and post-operative recovery using the NGENUITY 1.5 3D Visualization System and ADi digital surgical planning platform. Healthcare currently contributes 22% of consolidated revenue, with management targeting 70-80% over the long term; the hospital segment accounts for around 70% of group gross profit but only about 15% of operating profit, indicating it is still in a scaling phase. Retail provides cash-flow stability to fund healthcare expansion. Other group entities include associate SAIA Educational Support Services, optical retail, talent services, and Bahrain-based subsidiaries Salamath Import & Exports, Sky International Trading and Prudential Management Services. In FY26, consolidated revenue was Rs 161.68 crore (+67% YoY) with PAT of Rs 12.3 crore (over 10x YoY) and the first positive operating cash flow of Rs 6.1 crore. Reported FY26 cost shape shows materials at 0% of revenue, employees at 5.1%, other opex at 11.2%, depreciation at 1.3% and capex at 1.9% of revenue. FY26 EBITDA margin was 9.6%, with management guiding 18-20% across FY26-FY29 and flagging an FY27 capex need of around Rs 50 crore.
Scorecard
Measured from the filed financials, judged against its Hospital peers · as of FY26 — not investment advice
Strengths
Concerns
Nothing flagged in the filed numbers.Charts
How has the market priced it — with filings on the timeline?
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Peers
How does it stack up on valuation, returns and growth?
Loading peers…
Financials
Quarterly & annual P&L, balance sheet, cash flow, ratios and segments.
Loading financials…
Ownership
Who owns it — and is the promoter stake clean?
Loading shareholding…
Sign up to see the full company file
Governance, sustainability, compliance, earnings calls, presentations, events, reactions and the full filings feed — free with an account.
Common questions
Answered from ABATE AS INDUSTRIES LIMITED's filed financials and exchange disclosures
What does ABATE AS INDUSTRIES LIMITED do?
ABATE AS INDUSTRIES LIMITED is a Healthcare Services company listed on BSE.
Is ABATE AS INDUSTRIES LIMITED profitable?
Yes. Over the trailing twelve months ABATE AS INDUSTRIES LIMITED reported a net profit of ₹12 Cr on revenue of ₹142 Cr.
Does ABATE AS INDUSTRIES LIMITED pay a dividend?
Not in the latest reported year — ABATE AS INDUSTRIES LIMITED's dividend payout for FY26 was nil.
Is ABATE AS INDUSTRIES LIMITED debt-free?
No. It reported borrowings of ₹9.55 Cr on its 31 Mar 2026 balance sheet, or net debt of ₹6.01 Cr after cash. Debt stands at 0.05× equity. That is lower than 87% of its 24 Hospital peers.
Is ABATE AS INDUSTRIES LIMITED expensive compared with its peers?
On trailing P/E, ABATE AS INDUSTRIES LIMITED ranks 6 of 30 in Hospital — cheaper than 83% of them, against an industry median of 42.0×. This is a position, not a valuation judgement.
How much does the ABATE AS INDUSTRIES LIMITED share price move in a day?
On a typical session ABATE AS INDUSTRIES LIMITED moves 1.87% — that is the median absolute close-to-close move across its last 267 trading days. MarketPing measures each filing's price reaction against it.
Where can I track ABATE AS INDUSTRIES LIMITED's announcements?
Every NSE and BSE filing by ABATE AS INDUSTRIES LIMITED appears on this page, AI-summarised, alongside the price reaction that followed it. Follow the company to get each new filing on WhatsApp within minutes.
Figures are as last reported and may lag the latest filing. Not investment advice.